Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.

Merck & Co., Inc. - Cubist Pharmaceuticals

Merck & Co., Inc. acquires Cubist Pharmaceuticals

Announced: December 08, 2014

Type:           Acquisition
Disposition: Separate Entity
Terms:         Cash
Status:         Complete

Amount:       $ 8,400,000,000

Acquisition News

Add News

Date Title
Dec 08, 2014 firstwordpharma.com - Merck & Co. to buy Cubist for $8.4 billion
Merck & Co. to buy Cubist for $8.4 billion

Merck & Co., Inc. Other Acquisitions

Add Acquisition

Date Acquired Amount
Oct 10, 2017
KalVista Pharmaceuticals
$ 752,000,000
Sep 06, 2017
Rigontec GmbH
Undisclosed amount
Jul 11, 2016
StayWell Company
Undisclosed amount
Jun 09, 2016
Afferent Pharmaceuticals
$ 1,250,000,000
Jan 13, 2016
IOmet Pharma
Undisclosed amount
Jul 28, 2015
cCAM Biotherapeutics
$ 95,000,000
View more acquisitions »